January 16, 2017
Safe Orthopaedics to sell bone substitute for its Walnut cage for cervical surgeries in Europe
Safe Orthopaedics has started selling a bone substitute for its Walnut cage for cervical surgeries in Europe.
Pharmaceuticals, Biotechnology and Life Sciences
Category: Europe
January 16, 2017
Horizon Discovery broadens gene editing capabilities through extension of key CRISPR license and grant-funded research
Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing license with ERS Genomics to include…
January 13, 2017
Joseph Gunnar buys additional 122,500 Akers Biosciences common shares
Joseph Gunnar & Co., LLC, has exercised its over-allotment option to purchase an additional 122,500 common shares from the Akers Biosciences at $1.20 per share with the issuance of a further 61,250 warrants with an exercise price of $1.50 (the Warrants).
January 13, 2017
BioGaia’s probiotic to be launched in Thailand
BioGaia has signed an exclusive agreement with Abbott for the rights to commercialize BioGaia products in the area of paediatrics and gastroenterology in Thailand.
January 13, 2017
Norwegian Weifa to sell AFT’s pain and fever drugs in the Nordic region
Weifa has made a deal with New Zealand’s AFT Pharmaceuticals according to which it will sell drugs for pain relief and fever symptoms in the Nordic region (Norway, Sweden, Denmark, Finland and Iceland).
January 12, 2017
Mainstay Medical to sell its back pain device in Australia
Mainstay Medical International has applied for ReActiv8 to be admitted to the Australian Register of Therapeutic Goods (ARTG) which would…
January 12, 2017
Pixium Vision completes 10 implants in its Iris II study
Pixium Vision, a company developing and commercializing innovative bionic vision systems, has completed 10 implants in its Iris II study.
January 12, 2017
Trump says “pharma getting away with murder,” stocks slide
U.S. President-elect Donald Trump on Wednesday said pharmaceutical companies are “getting away with murder” in what they charge the government for medicines, and promised that would change, sending drugs stocks sharply lower.
January 12, 2017
Walloon (Belgium) government funds ASIT Biotech’s food allergies treatment research
The Walloon (Belgium) government has decided to fund its ASIT Biotech to help develop new drug candidates to treat the main food allergies caused by peanuts, cow’s milk and egg whites.
January 12, 2017
OptiBiotix with two abstracts at Berlin’s conference ProBiota
OptiBiotix Health will have its two abstracts presented at ProBiota 2017 in Berlin, which is taking place from February 1-3, 2017. ProBiota is the leading annual event for the global prebiotic, probiotic and the microbiota focused food and pharma industries.